Early Detection of Abnormal Coronary Flow Reserve in Asymptomatic Men at High Risk for Coronary Artery Disease Using Positron Emission Tomography

BackgroundThe objective of this study was to compare coronary flow reserve (CFR) as a measure of vascular integrity in asymptomatic middle-aged men with family history of coronary artery disease (CAD) and a high-risk lipid profile with men without risk factors for CAD using positron emission tomography (PET). Previous studies suggested that the assessment of CFR is a sensitive means to detect vascular abnormalities before angiographic appearance of CAD. N-13 ammonia PET scanning allows noninvasive evaluation of regional and global myocardial blood flow and thereby quantification of CFR. Methods and ResultsWe used dynamic N-13 ammonia PET imaging in conjunction with intravenous adenosine to assess regional and global CFR in asymptomatic middle-aged men with high risk (group 1, n=16) and men without any known risk factors (group 2, n= 11) for CAD. Group 1 patients were selected based on positive family history of CAD, one or more lipid abnormalities, and a normal stress test. No patient had history of diabetes or hypertension. A three-compartment tracer kinetic model developed and validated in our institution was used to calculate myocardial blood flow. Absolute myocardial blood flow (mL/100 g per minute) was calculated in five territories for each patient. CFR was defined as the ratio of blood flow during maximum pharmacological vasodilatation to blood flow at rest. Comparisons of CFR between the two groups of patients were performed. The mean age was similar between groups (group 1, 49.3±0.5 years; group 2, 48.1±8.7 years; P=NS). Group 1 had higher total cholesterol (mg/dL) (241±43 versus 173±34, P<.001), total cholesterol to high-density lipoprotein cholesterol ratio (6.4±1.6 versus 4.1±1.4, P<.001), and low-density lipoprotein cholesterol (mg/dL) (167±33 versus 107±32). No group 1 patient had evidence of ischemia by exercise ECG or exercise or pharmacological radionuclide perfusion studies. The mean global absolute myocardial blood flow at rest was not significantly different among groups (group 1, 76±18; group 2, 66±8; P=NS; (in mL/100 g per minute). However, blood flow after adenosine infusion was higher for group 2 (group 1, 217±56; group 2, 264±39; P<.001), which resulted in a larger CFR for group 2 (group 1, 2.93±0.86; group 2, 4.27±0.52; P<.001). Univariate linear regression analysis revealed significant negative correlation of CFR to total cholesterol (P<.05, r=−.41), low-density lipoprotein (P<.05, r= −.38), and total cholesterol to high-density lipoprotein cholesterol ratio (P<.05, r= −.47). ConclusionsNoninvasive quantification of absolute myocardial blood flow by N-13 ammonia PET allows the detection of abnormal vasodilatory response to intravenous adenosine in male patients with family history of CAD and high-risk lipid profiles. Early assessment of alterations of vascular reactivity to adenosine in relation to high-risk lipid profiles in asymptomatic men may allow early detection of preclinical atherosclerosis and may initiate modification and/or elimination of risk factors that may slow, retard, or even reverse the progression of CAD.

[1]  H. Drexler,et al.  Endothelial Dysfunction of the Coronary Microvasculature Is Associated With Impaired Coronary Blood Flow Regulation in Patients With Early Atherosclerosis , 1991, Circulation.

[2]  O Muzik,et al.  Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  J. Loscalzo,et al.  Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. , 1990, The Journal of clinical investigation.

[4]  A. Jacobs,et al.  Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. , 1992, Journal of the American College of Cardiology.

[5]  A. Herman,et al.  Effect of Hypercholesterolemia on Vascular Reactivity in the Rabbit: I. Endothelium‐Dependent and Endothelium‐Independent Contractions and Relaxations in Isolated Arteries of Control and Hypercholesterolemic Rabbits , 1986, Circulation research.

[6]  G D Hutchins,et al.  Automated region definition for cardiac nitrogen-13-ammonia PET imaging. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  J P Matts,et al.  Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH) , 1990, The New England journal of medicine.

[8]  J. Parrillo,et al.  Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain. , 1987, Journal of the American College of Cardiology.

[9]  A. M. Lefer,et al.  Lack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol-fed rabbits. , 1989, The American journal of physiology.

[10]  D. Kuhl,et al.  N‐13 Ammonia as an Indicator of Myocardial Blood Flow , 1981, Circulation.

[11]  P. Ganz,et al.  Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. , 1989, Circulation.

[12]  W. Kübler,et al.  Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. , 1984, Circulation.

[13]  D. Berman,et al.  Alternative referent standards for cardiac normality. Implications for diagnostic testing. , 1984, Annals of internal medicine.

[14]  J. Huttunen,et al.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. , 1987, The New England journal of medicine.

[15]  A. L'Abbate,et al.  Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. , 1991, Journal of the American College of Cardiology.

[16]  Adriaan A. Lammertsma,et al.  Noninvasive Quantification of Regional Myocardial Blood Flow in Coronary Artery Disease With Oxygen‐15–Labeled Carbon Dioxide Inhalation and Positron Emission Tomography , 1991, Circulation.

[17]  S. Azen,et al.  Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up. , 1990, JAMA.

[18]  K. Gould,et al.  Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial , 1990, The Lancet.

[19]  H. Schelbert,et al.  Quantification of absolute myocardial perfusion at rest and during exercise with positron emission tomography after human cardiac transplantation. , 1991, Journal of the American College of Cardiology.

[20]  L. Ignarro,et al.  Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. , 1986, The Journal of pharmacology and experimental therapeutics.

[21]  A. Nitenberg,et al.  Impairment of Coronary Vascular Reserve and ACh-Induced Coronary Vasodilation in Diabetic Patients With Angiographically Normal Coronary Arteries and Normal Left Ventricular Systolic Function , 1993, Diabetes.

[22]  An automated analysis program for the evaluation of cardiac PET studies: initial results in the detection and localization of coronary artery disease using nitrogen-13-ammonia. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  A. Yeung,et al.  Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. , 1990, Circulation.

[24]  M. Marcus,et al.  Decreased coronary reserve: a mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries. , 1982, The New England journal of medicine.

[25]  M. Schwaiger,et al.  Determination of extent and location of coronary artery disease in patients without prior myocardial infarction by thallium-201 tomography with pharmacologic stress. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  D E Kuhl,et al.  Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. , 1991, The American journal of cardiology.

[27]  J J Albers,et al.  Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. , 1990, The New England journal of medicine.

[28]  O. Hess,et al.  Influence of Serum Cholesterol and Other Coronary Risk Factors on Vasomotion of Angiographically Normal Coronary Arteries , 1993, Circulation.

[29]  G. Assmann,et al.  The Prospective Cardiovascular Münster Study: prevalence and prognostic significance of hyperlipidemia in men with systemic hypertension. , 1987, The American journal of cardiology.

[30]  K. Zitnay,et al.  Loss of Selective Endothelial Cell Vasoactive Functions Caused by Hypercholesterolemia in Pig Coronary Arteries , 1988, Circulation research.

[31]  The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. , 1984, JAMA.

[32]  D E Kuhl,et al.  Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. , 1990, Journal of the American College of Cardiology.

[33]  D. Ornish Can lifestyle changes reverse coronary heart disease? , 1993, World review of nutrition and dietetics.

[34]  P. Vanhoutte,et al.  Flow-induced release of endothelium-derived relaxing factor. , 1986, The American journal of physiology.